Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:01 AM
Ignite Modification Date:
2025-12-25 @ 3:01 AM
NCT ID:
NCT02426333
Eligibility Criteria:
Inclusion Criteria:
* Patients with metastatic castration resistant prostate cancer who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated
* Age ≥18 years
* Feasible to collect blood samples from
* Life expectancy of \> 6 months
* Measurable disease
* Able and willing to give written informed consent prior to screening and enrollment
Exclusion Criteria:
* other anticancer therapies
* potent CYP3A4 inducers
* herbal medicine that could interfere with abiraterone exposure
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT02426333
Study Brief:
Protocol Section:
NCT02426333